Laumart

Omeprazole, the active ingredient in Laumart, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid production and is used to treat acid‑related conditions such as gastro‑esophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Laumart as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established distribution networks across Europe, Asia and the Americas.

Omeprazole is indicated for several acid‑related disorders that involve excessive gastric acid secretion.

Gastroesophageal reflux disease (GERD): alleviates heartburn and esophageal irritation by maintaining higher gastric pH. Peptic ulcer disease: promotes ulcer healing by suppressing acid secretion. Helicobacter pylori eradication therapy: enhances antibiotic efficacy by creating a less acidic gastric environment. Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid in this rare neuroendocrine tumor.

Omeprazole may cause a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects: - Headache - Abdominal pain - Diarrhea - Nausea - Flatulence - Constipation

Serious or Rare Side Effects: - Clostridioides difficile infection - Severe allergic reactions (anaphylaxis, angioedema) - Elevated liver enzymes - Hypomagnesemia with prolonged use - Increased risk of bone fractures - Interstitial nephritis

When prescribing or dispensing Laumart, consider the following precautions.

Assess renal function: adjust use in severe renal impairment. Monitor magnesium levels: prolonged therapy may cause hypomagnesemia. Avoid abrupt discontinuation: may lead to rebound acid hypersecretion. Use with caution in elderly patients: higher risk of fractures. Review concomitant medications: potential for drug interactions. Store at room temperature: keep in the original pack, protect from moisture.

Omeprazole can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption and efficacy. - Methotrexate (high dose): increased toxicity.

Moderate Interactions (Monitor Closely): - Diazepam: increased serum concentration. - Phenytoin: decreased plasma levels. - Digoxin: increased serum concentration.